H
Hy2care
Hy2Care develops the CartRevive Hydrogel implant for treating traumatic cartilage defects, enabling natural healing of the cartilage
About Hy2care
Revolutionizing cartilage recovery: Hy2Care’s CartRevive hydrogel implant realizes optimal repair of cartilage defects. After sports mishaps, slips, or falls, our patented hydrogel offers a scaffold of joint-matching composition, guiding natural cell growth and enabling the body to heal itself. Currently under clinical examination in the Netherlands for EU approval, with US trials coming up. Dive into the future of joint repair with us!
Source: Dealroom company dataNews
Open roles
Hy2care in the Geleen ecosystem
The Hy2care office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Innovation Council
Series A3 investors entered at this stage
Brightlands Venture Partners
EIC Fund
LIOF - Limburg Regional Development Agency
Source: Dealroom Talent Intelligence.
See Hy2care on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
